Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exelixis, Inc.    EXEL

EXELIXIS, INC.

(EXEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EXELIXIS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

11/05/2020 | 04:17pm EST
Item 2.02. Results of Operations and Financial Condition.
On November 5, 2020, Exelixis, Inc. ("Exelixis") issued a press release
announcing its financial results for the quarter ended October 2, 2020, and
providing a corporate update. A copy of such press release is furnished herewith
as Exhibit 99.1 and is incorporated herein by reference.
The information in this report, including the exhibit hereto, shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that section or
Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The
information contained in this report and in the accompanying exhibit shall not
be incorporated by reference into any filing with the U.S. Securities and
Exchange Commission made by Exelixis, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.


Item 9.01. Financial Statements and Exhibits.

(d)   Exhibits.
  Exhibit Number                Exhibit Description

       99.1                 Press Release issued November
                          5, 2020.
      101.INS             XBRL Instance Document                The XBRL

instance document does not appear in the

                                                                Interactive 

Data File because its XBRL tags are embedded

                                                                within the Inline XBRL document.
      101.SCH             Inline XBRL Taxonomy Extension
                          Schema Document
      101.CAL             Inline XBRL Taxonomy Extension
                          Calculation Linkbase Document
      101.DEF             Inline XBRL Taxonomy Extension
                          Definition Linkbase Document
      101.LAB             Inline XBRL Taxonomy Extension
                          Labels Linkbase Document
      101.PRE             Inline XBRL Taxonomy Extension
                          Presentation Linkbase Document
        104               Cover Page Interactive Data           Formatted

as Inline XBRL and contained in Exhibit 101.

                          File



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about EXELIXIS, INC.
01/11EXELIXIS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/11EXELIXIS : Reports Preliminary Q4 Revenue of $270 Million, Issues 2021 Guidance
MT
01/10EXELIXIS : Announces Preliminary Fourth Quarter and Full Year 2020 Financial Res..
BU
01/04EXELIXIS : to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conferen..
BU
2020EXELIXIS : Announces Cabozantinib Significantly Improved Progression-Free Surviv..
AQ
2020EXELIXIS : Phase 3 Study of Cabometyx in Thyroid Cancer Meets Co-Primary Endpoin..
MT
2020EXELIXIS : Announces Cabozantinib Significantly Improved Progression-Free Surviv..
BU
2020EXELIXIS : XWPharma Names Michael M. Morrissey, PhD to Board of Directors
AQ
2020Dr. Reddy's Unit Signs In-Licensing Deal with US Drug Discovery Company Exeli..
MT
2020INSIDER TRENDS : Regulus Therapeutics Insider Gets Stock Award, Extends Buy Tren..
MT
More news